Market Cap

Combigene AB Market Capitalization:

kr55.4 Million

SEK as of Jan. 1, 2024

US$5.5 Million

business Combigene AB Company Profile

Combigene AB Main Stock Listing

OMX: COMBI

Market Capitalization History of Combigene AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Combigene AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr55.4 M -69.13%
Jan. 1, 2023 kr179.6 M -18.60%
Jan. 1, 2022 kr220.6 M -6.52%
Jan. 1, 2021 kr236.0 M -43.81%
Jan. 1, 2020 kr420.1 M -21.25%
Jan. 1, 2019 kr533.4 M -28.20%
Jan. 1, 2018 kr742.9 M 7.47%
Jan. 1, 2017 kr691.2 M -64.56%
Jan. 1, 2016 kr1.95 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Combigene AB Categories

Sweden languages Healthcare languages Biotechnology
Sweden Healthcare Sweden Biotechnology

Stocks & Indices

Combigene AB has the following listings and related stock indices.


Stock: OMX: COMBI

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.